The Latin American Neurotrauma Study : Biomarkers in Traumatic Brain Injury

The LATINO-BIO-TBI study is a multicenter, international, prospective project that seeks to investigate serum biomarker levels (GFAP and UCH-L1) in connection to the severity of traumatic brain injury (TBI) and its functional outcomes. The goal is to improve risk stratification and clinical decision-making in the management TBI patients.